As it can act on multiple targets in different tissues, inhibition of MSH6 and SF3B1 by Cyclophosphamide, as well as inhibition of SMAD4 and PSMD2 and activation of ASAH1 and MLST8d by Doxorubicin can have bidirectional effects on AF. Here, SMAD4 is linked to atrial fibrillation.